Cancer cell lines A375M, ILSA, Mel624, and pMelL showed a reduction of RAD51 foci after blocking the second DSB non-homologous end-joining repair pathway by treating cells with a DNA-PK inhibitor. The gene discussed is RAD51; the disease is cancer.